Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis
NCT04096573
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
company decision
Conditions
Ulcerative Colitis
Interventions
DRUG:
LC51-0255
DRUG:
Placebo
Sponsor
LG Chem